Clinical research during a public health emergency: A systematic review of severe pandemic influenza management

Critical Care Medicine

Volumn 41, Issue 5, 2013, Pages 1345-1352

  Ortiz, Justin R ^a   Rudd, Kristina E ^a   Clark, Danielle V ^b   Jacob, Shevin T ^a   West, T Eoin ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

clinical trial; critical care; developing countries; influenza; review

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE;

2009 H1N1 INFLUENZA; ADULT RESPIRATORY DISTRESS SYNDROME; APHERESIS; CLINICAL RESEARCH; COCHRANE LIBRARY; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; EMBASE; EMERGENCY HEALTH SERVICE; EXTRACORPOREAL OXYGENATION; HUMAN; INTENSIVE CARE; LOWEST INCOME GROUP; MEDLINE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW;

BIOMEDICAL RESEARCH; CRITICAL CARE; DISEASE OUTBREAKS; EMERGENCIES; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; PANDEMICS; PUBLIC HEALTH; RESEARCH DESIGN; UNITED STATES;

EID: 84876664558     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182771386     Document Type: Review

References (39)

1. Lapinsky SE: Epidemic viral pneumonia. Curr Opin Infect Dis 2010; 23:139-144
2. World Health Organization: Clinical management of infuenza and other acute respiratory illness in resource-limited settings: Learning from the infuenza pandemic (H1N1) 2009. Available at: http://www.who.int/infuenza/ patient-care/clinical/858-WHOGIPReport-A4-WEB-FA.pdf. Accessed June 6, 2102
3. Dawood FS, Iuliano AD, Reed C, et al: Estimated global mortality associated with the frst 12 months of 2009 pandemic infuenza A H1N1 virus circulation: A modelling study. Lancet Infect Dis 2012; 12:687-695
4. World Health Organization: Pandemic (H1N1) 2009, Ukraine. Available at: http://www.who.int/csr/don/2009-11-01/en/index.html. Accessed September 1, 2012
5. World Health Organization: Clinical management of human infection with pandemic (H1N1) 2009: Revised guidance. Available at: http://www.who.int/csr/ resources/publications/swinefu/clinical-management/en/index.html. Accessed June 1, 2012
6. World Health Organization: Clinical management of adult patients with complications of pandemic infuenza A (H1N1) 2009: Emergency guidelines for the management of patients with severe respiratory distress and shock in district hospitals in limited-resource settings. Available at: http://www.who.int/csr/ resources/publications/swinefu/imai-h1n1.pdf. Accessed June 13, 2012
7. Nicolay N, Callaghan MA, Domegan LM, et al: Epidemiology, clinical characteristics and resource implications of pandemic (H1N1) 2009 in intensive care units in Ireland. Crit Care Resusc 2010; 12:255-261
8. Richard JC, Pham T, Brun-Buisson C, et al; the REVA study group: Interest of a simple on-line screening registry for measuring ICU burden related to an infuenza pandemic. Crit Care 2012; 16:R118
9. Webb SA, Pettilä V, Seppelt I, et al: ANZIC Infuenza Investigators: Critical care services and 2009 H1N1 infuenza in Australia and New Zealand. N Engl J Med 2009; 361:1925-1934
10. World Health Organization: WHO guidelines for pharmacological management of pandemic (H1N1) 2009 infuenza and other infu-enza viruses. Available at: http://www.who.int/csr/resources/pub-lications/swinefu/h1n1-use-antivirals- 20090820/en/index.html. Accessed June 6, 2012
11. World Health Organization: WHO Public Health Research Agenda for Infuenza Ver. 1, 2009. Available at: http://apps.who.int/csr/dis-ease/infuenza/research- agenda/en/index.html. Accessed June 6, 2012
12. World Health Organization: WHO Public Health Research Agenda for Infuenza Ver. 1, 2009. Available at: http://apps.who.int/csr/disease/infuenza/research- agenda/en/index.html. Accessed June 6, 2012
13. Perdue ML, Nguyen T: The WHO research agenda for infuenza: two years later. Bull World Health Organ 2012; 90:246
14. Gallo V, Egger M, McCormack V, et al: STROBE Statement: STrengthening the Reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): An extension of the STROBE Statement. PLoS Med 2011; 8:e1001117
15. Liberati A, Altman DG, Tetzlaff J, et al: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339:b2700
16. Moher D, Hopewell S, Schulz KF, et al: CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340:c869
17. Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Ver. 5.1.0. 2011. Available at: http://www.cochrane-handbook.org/. Accessed June 6, 2012
18. Brun-Buisson C, Richard JC, Mercat A, et al; REVA-SRLF A/H1N1v 2009 Registry Group: Early corticosteroids in severe infuenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011; 183:1200-1206
19. Freed DH, Henzler D, White CW, et al: Canadian Critical Care Trials Group: Extracorporeal lung support for patients who had severe respiratory failure secondary to infuenza A (H1N1) 2009 infection in Canada. Can J Anaesth 2010; 57:240-247
20. Hung I F, To KK, Lee CK, et al: Convalescent plasma treatment reduced mortality in patients with severe pandemic infuenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011; 52:447-456
21. Linko R, Pettilä V, Ruokonen E, et al: FINNH1N1-STUDY GROUP: Corticosteroid therapy in intensive care unit patients with PCR-confrmed infuenza A(H1N1) infection in Finland. Acta Anaesthesiol Scand 2011; 55:971-979
22. Martin-Loeches I, Lisboa T, Rhodes A, et al; ESICM H1N1 Registry Contributors: Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v infuenza A infection. Intensive Care Med 2011; 37:272-283
23. Noah MA, Peek GJ, Finney SJ, et al: Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 infuenza A(H1N1). JAMA 2011; 306:1659-1668
24. Roch A, Lepaul-Ercole R, Grisoli D, et al: Extracorporeal membrane oxygenation for severe infuenza A (H1N1) acute respiratory distress syndrome: A prospective observational comparative study. Intensive Care Med 2010; 36:1899-1905
25. Peter JV, John P, Graham PL, et al: Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: Meta-analysis. BMJ 2008; 336:1006-1009
26. Tang BM, Craig JC, Eslick GD, et al: Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis. Crit Care Med 2009; 37:1594-1603
27. Mitchell MD, Mikkelsen ME, Umscheid CA, et al: A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 infuenza pandemic. Crit Care Med 2010; 38:1398-1404
28. Adhikari NK, Fowler RA, Bhagwanjee S, et al: Critical care and the global burden of critical illness in adults. Lancet 2010; 376:1339-1346
29. Belle J, Cohen H, Shindo N, et al: Infuenza preparedness in low-resource settings: A look at oxygen delivery in 12 African countries. J Infect Dev Ctries 2010; 4:419-424
30. Hsia RY, Mbembati NA, Macfarlane S, et al: Access to emergency and surgical care in sub-Saharan Africa: The infrastructure gap. Health Policy Plan 2012; 27:234-244
31. InFACT: A global critical care research response to H1N1. Lancet 2010; 375(9708): 11-13
32. Fowler RA, Webb SA, Rowan KM, et al: Early observational research and registries during the 2009-2010 infuenza A pandemic. Crit Care Med 2010; 38(4 Suppl):e120-e132
33. Cheng AC, West TE, Limmathurotsakul D, et al: Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med 2008; 5:e175
34. Dünser MW, Festic E, Dondorp A, et al; Global Intensive Care Working Group of European Society of Intensive Care Medicine: Recommendations for sepsis management in resource-limited settings. Intensive Care Med 2012; 38:557-574
35. Riviello ED, Letchford S, Achieng L, et al: Critical care in resource-poor settings: Lessons learned and future directions. Crit Care Med 2011; 39:860-867
36. Dondorp AM, Fanello CI, Hendriksen IC, et al; AQUAMAT group: Artesu-nate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376:1647-1657
37. Gomes MF, Faiz MA, Gyapong JO, et al; Study 13 Research Group: Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet 2009; 373: 557-566
38. Maitland K, Kiguli S, Opoka RO, et al; FEAST Trial Group: Mortality after fuid bolus in African children with severe infection. N Engl J Med 2011; 364:2483-2495
39. Wellcome Trust: New international consortium to prepare research community for future pandemics. Available at: http://www.wellcome.ac.uk/News/ Media-offce/Press-releases/2011/WTVM053638.htm. Accessed June 23, 2012